Quarterly Result29 May 2026, 04:51 pm
Brawn Biotech Audited Results: FY26 Revenue ₹1,743.18 Lacs
AI Summary
Brawn Biotech Ltd's Board of Directors approved the audited financial results for the quarter and year ended March 31, 2026, in a meeting held on May 29, 2026. The company's revenue from operations for the year ended March 31, 2026, stood at ₹1,743.18 Lacs. The meeting commenced at 3:30 PM and concluded at 4:00 PM. The results have been prepared in compliance with Indian Accounting Standards.
Key Highlights
- Brawn Biotech's Board approved audited financial results for FY26 on May 29, 2026.
- FY26 revenue from operations reached ₹1,743.18 Lacs.
- The audit was conducted by the company’s statutory auditors.
- Meeting commenced at 3:30 PM and concluded at 4:00 PM on May 29, 2026.
- Results comply with Companies (Indian Accounting Standards) Rules, 2015.
Price Impact
More from BRAWN